Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,deferredLongTermAssetCharges,changeToLiabilities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,currency,exchange,marketCap,gmtOffSetMilliseconds,esgPopulated,tradeable,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,market,exchangeDataDelayedBy,shortName,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,country,website,maxAge,address1,fax,industry
t0,NN6.DE,7923972.0,12903800,,,1159188,,685756,364275,3065805,2092516,2092516,659097,-5867,,,,473432,7360854,5268339,4295050,-933329,,685756,685756,66269.0,3179969.0,7990241.0,639441.0,11170211.0,9330703.0,32043.0,-7463895.0,830065.0,6123433.0,6068.0,1163658.0,2199904.0,1201792.0,6123433.0,750.0,11072124.0,25000.0,7310346.0,150000.0,2566077.0,358671.0,,0,8872220.0,en-US,US,EQUITY,False,Delayed Quote,10.26,1630578332,-0.13999939,10.34,10.42,10.08,25118,EUR,GER,132392992,7200000,False,False,REGULAR,2,-1.346148,10.08 - 10.42,de_market,0,NANOREPRO AG,10.4,10.12,10.28,2000,2200,finmb_30587543,XETRA,NanoRepro AG,EUR,120606,203973,9.200827,8.686795,1.059174 - 22.4,-12.139999,-0.5419643,1.059174,22.4,1596106740,1596106740,1596106740,56.37363,0.182,0.856,6.929714,3.330286,0.48058057,9.312394,0.9476061,0.10175751,11.985982,15,Europe/Berlin,CEST,-4.48,,,22.4,1.06,6.93,9.31,120.61k,203.97k,12.9M,,8.21M,8.55%,1.49%,,,,,,,,,,,0.00%,,,,,"Dec 31, 2020","Dec 31, 2020",10.01%,27.49%,36.41%,27.29%,16.93M,1.81,"1,520.60%",7.63M,4.67M,1.69M,0.18,,1.16M,0.12,1.35M,16.92,5.03,0.86,-1.1M,-5.39M,Value,35037,Healthcare,15,"NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.",Marburg,49 6421 951449,Germany,http://www.nanorepro.com,86400,Untergasse 8,49 6421 951451,Diagnostics & Research
t-1,NN6.DE,7923972.0,12903800,,,1159188,,685756,364275,3065805,2092516,2092516,659097,-5867,,,,473432,7360854,5268339,4295050,-933329,,685756,685756,66269.0,3179969.0,7990241.0,639441.0,11170211.0,9330703.0,32043.0,-7463895.0,830065.0,6123433.0,6068.0,1163658.0,2199904.0,1201792.0,6123433.0,750.0,11072124.0,25000.0,7310346.0,150000.0,2566077.0,358671.0,,0,8872220.0,en-US,US,EQUITY,False,Delayed Quote,10.26,1630578332,-0.13999939,10.34,10.42,10.08,25118,EUR,GER,132392992,7200000,False,False,REGULAR,2,-1.346148,10.08 - 10.42,de_market,0,NANOREPRO AG,10.4,10.12,10.28,2000,2200,finmb_30587543,XETRA,NanoRepro AG,EUR,120606,203973,9.200827,8.686795,1.059174 - 22.4,-12.139999,-0.5419643,1.059174,22.4,1596106740,1596106740,1596106740,56.37363,0.182,0.856,6.929714,3.330286,0.48058057,9.312394,0.9476061,0.10175751,11.985982,15,Europe/Berlin,CEST,-4.48,,,22.4,1.06,6.93,9.31,120.61k,203.97k,12.9M,,8.21M,8.55%,1.49%,,,,,,,,,,,0.00%,,,,,"Dec 31, 2020","Dec 31, 2020",10.01%,27.49%,36.41%,27.29%,16.93M,1.81,"1,520.60%",7.63M,4.67M,1.69M,0.18,,1.16M,0.12,1.35M,16.92,5.03,0.86,-1.1M,-5.39M,Value,35037,Healthcare,15,"NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.",Marburg,49 6421 951449,Germany,http://www.nanorepro.com,86400,Untergasse 8,49 6421 951451,Diagnostics & Research
t-2,NN6.DE,4379116.0,12903800,,,230996,,161722,187678,749495,234085,234085,271512,-3283,,,,69274,1103850,869765,354355,-3089,,161722,161722,2239617.0,538457.0,6618733.0,298776.0,7157191.0,9330703.0,12569.0,-8835403.0,,6123433.0,474808.0,2015622.0,388457.0,4418.0,6123433.0,1670.0,4416096.0,25000.0,825571.0,150000.0,1562334.0,64263.0,459500.0,0,4027639.0,en-US,US,EQUITY,False,Delayed Quote,10.26,1630578332,-0.13999939,10.34,10.42,10.08,25118,EUR,GER,132392992,7200000,False,False,REGULAR,2,-1.346148,10.08 - 10.42,de_market,0,NANOREPRO AG,10.4,10.12,10.28,2000,2200,finmb_30587543,XETRA,NanoRepro AG,EUR,120606,203973,9.200827,8.686795,1.059174 - 22.4,-12.139999,-0.5419643,1.059174,22.4,1596106740,1596106740,1596106740,56.37363,0.182,0.856,6.929714,3.330286,0.48058057,9.312394,0.9476061,0.10175751,11.985982,15,Europe/Berlin,CEST,-4.48,,,22.4,1.06,6.93,9.31,120.61k,203.97k,12.9M,,8.21M,8.55%,1.49%,,,,,,,,,,,0.00%,,,,,"Dec 31, 2020","Dec 31, 2020",10.01%,27.49%,36.41%,27.29%,16.93M,1.81,"1,520.60%",7.63M,4.67M,1.69M,0.18,,1.16M,0.12,1.35M,16.92,5.03,0.86,-1.1M,-5.39M,Value,35037,Healthcare,15,"NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.",Marburg,49 6421 951449,Germany,http://www.nanorepro.com,86400,Untergasse 8,49 6421 951451,Diagnostics & Research
t-3,NN6.DE,4379116.0,12903800,,,230996,,161722,187678,749495,234085,234085,271512,-3283,,,,69274,1103850,869765,354355,-3089,,161722,161722,2239617.0,538457.0,6618733.0,298776.0,7157191.0,9330703.0,12569.0,-8835403.0,,6123433.0,474808.0,2015622.0,388457.0,4418.0,6123433.0,1670.0,4416096.0,25000.0,825571.0,150000.0,1562334.0,64263.0,459500.0,0,4027639.0,en-US,US,EQUITY,False,Delayed Quote,10.26,1630578332,-0.13999939,10.34,10.42,10.08,25118,EUR,GER,132392992,7200000,False,False,REGULAR,2,-1.346148,10.08 - 10.42,de_market,0,NANOREPRO AG,10.4,10.12,10.28,2000,2200,finmb_30587543,XETRA,NanoRepro AG,EUR,120606,203973,9.200827,8.686795,1.059174 - 22.4,-12.139999,-0.5419643,1.059174,22.4,1596106740,1596106740,1596106740,56.37363,0.182,0.856,6.929714,3.330286,0.48058057,9.312394,0.9476061,0.10175751,11.985982,15,Europe/Berlin,CEST,-4.48,,,22.4,1.06,6.93,9.31,120.61k,203.97k,12.9M,,8.21M,8.55%,1.49%,,,,,,,,,,,0.00%,,,,,"Dec 31, 2020","Dec 31, 2020",10.01%,27.49%,36.41%,27.29%,16.93M,1.81,"1,520.60%",7.63M,4.67M,1.69M,0.18,,1.16M,0.12,1.35M,16.92,5.03,0.86,-1.1M,-5.39M,Value,35037,Healthcare,15,"NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.",Marburg,49 6421 951449,Germany,http://www.nanorepro.com,86400,Untergasse 8,49 6421 951451,Diagnostics & Research
